| . | Placebo N = 122 . | Promestriene N = 119 . |
|---|---|---|
| Age, months, mean (±SD) | 14.9 (±5.1) | 15.1 (±4.8) |
| Age at surgery, months, mean (±SD) | 17.4 (±5.2) | 17.5 (±5.0) |
| Weight, kg, mean (±SD) | 10.5 (±1.9) | 10.3 (±2.0) |
| Height, cm, mean (±SD) | 77.4 (±5.6) | 77.9 (±6.6) |
| Penile length, cm, mean (±SD) | 4.0 (±0.6) | 3.9 (±0.5) |
| Diameter, cm, mean (±SD) | 1.48 (±0.18) | 1.46 (±0.26) |
| Ventral aspect (Hypoplasia), n (%) | 104 (85) | 109 (92) |
| Meatal position, n (%) Distal Mid shaft Proximal | 44 (36) 59 (48) 19 (16) | 50 (42) 49 (41) 20 (17) |
| Division of corpus spongiosum, n (%) Distal Mid shaft Proximal | 2 (1) 74 (61) 46 (38) | 3 (2) 78 (66) 38 (32) |
| Curvature, n (%) No curvature Mild curvature Severe curvature | 6 (5) 74 (61) 42 (34) | 5 (4) 79 (66) 35 (30) |
| Preputial aspect, n (%) Complete Uncomplete | 0 (0) 122 (100) | 1 (1) 118 (99) |
| Previous treatment with androgen, n (%) | 13 (11) | 14 (12) |
| Previous treatment with HCG, n( %) | 9 (7) | 7 (6) |
| . | Placebo N = 122 . | Promestriene N = 119 . |
|---|---|---|
| Age, months, mean (±SD) | 14.9 (±5.1) | 15.1 (±4.8) |
| Age at surgery, months, mean (±SD) | 17.4 (±5.2) | 17.5 (±5.0) |
| Weight, kg, mean (±SD) | 10.5 (±1.9) | 10.3 (±2.0) |
| Height, cm, mean (±SD) | 77.4 (±5.6) | 77.9 (±6.6) |
| Penile length, cm, mean (±SD) | 4.0 (±0.6) | 3.9 (±0.5) |
| Diameter, cm, mean (±SD) | 1.48 (±0.18) | 1.46 (±0.26) |
| Ventral aspect (Hypoplasia), n (%) | 104 (85) | 109 (92) |
| Meatal position, n (%) Distal Mid shaft Proximal | 44 (36) 59 (48) 19 (16) | 50 (42) 49 (41) 20 (17) |
| Division of corpus spongiosum, n (%) Distal Mid shaft Proximal | 2 (1) 74 (61) 46 (38) | 3 (2) 78 (66) 38 (32) |
| Curvature, n (%) No curvature Mild curvature Severe curvature | 6 (5) 74 (61) 42 (34) | 5 (4) 79 (66) 35 (30) |
| Preputial aspect, n (%) Complete Uncomplete | 0 (0) 122 (100) | 1 (1) 118 (99) |
| Previous treatment with androgen, n (%) | 13 (11) | 14 (12) |
| Previous treatment with HCG, n( %) | 9 (7) | 7 (6) |
| . | Placebo N = 122 . | Promestriene N = 119 . |
|---|---|---|
| Age, months, mean (±SD) | 14.9 (±5.1) | 15.1 (±4.8) |
| Age at surgery, months, mean (±SD) | 17.4 (±5.2) | 17.5 (±5.0) |
| Weight, kg, mean (±SD) | 10.5 (±1.9) | 10.3 (±2.0) |
| Height, cm, mean (±SD) | 77.4 (±5.6) | 77.9 (±6.6) |
| Penile length, cm, mean (±SD) | 4.0 (±0.6) | 3.9 (±0.5) |
| Diameter, cm, mean (±SD) | 1.48 (±0.18) | 1.46 (±0.26) |
| Ventral aspect (Hypoplasia), n (%) | 104 (85) | 109 (92) |
| Meatal position, n (%) Distal Mid shaft Proximal | 44 (36) 59 (48) 19 (16) | 50 (42) 49 (41) 20 (17) |
| Division of corpus spongiosum, n (%) Distal Mid shaft Proximal | 2 (1) 74 (61) 46 (38) | 3 (2) 78 (66) 38 (32) |
| Curvature, n (%) No curvature Mild curvature Severe curvature | 6 (5) 74 (61) 42 (34) | 5 (4) 79 (66) 35 (30) |
| Preputial aspect, n (%) Complete Uncomplete | 0 (0) 122 (100) | 1 (1) 118 (99) |
| Previous treatment with androgen, n (%) | 13 (11) | 14 (12) |
| Previous treatment with HCG, n( %) | 9 (7) | 7 (6) |
| . | Placebo N = 122 . | Promestriene N = 119 . |
|---|---|---|
| Age, months, mean (±SD) | 14.9 (±5.1) | 15.1 (±4.8) |
| Age at surgery, months, mean (±SD) | 17.4 (±5.2) | 17.5 (±5.0) |
| Weight, kg, mean (±SD) | 10.5 (±1.9) | 10.3 (±2.0) |
| Height, cm, mean (±SD) | 77.4 (±5.6) | 77.9 (±6.6) |
| Penile length, cm, mean (±SD) | 4.0 (±0.6) | 3.9 (±0.5) |
| Diameter, cm, mean (±SD) | 1.48 (±0.18) | 1.46 (±0.26) |
| Ventral aspect (Hypoplasia), n (%) | 104 (85) | 109 (92) |
| Meatal position, n (%) Distal Mid shaft Proximal | 44 (36) 59 (48) 19 (16) | 50 (42) 49 (41) 20 (17) |
| Division of corpus spongiosum, n (%) Distal Mid shaft Proximal | 2 (1) 74 (61) 46 (38) | 3 (2) 78 (66) 38 (32) |
| Curvature, n (%) No curvature Mild curvature Severe curvature | 6 (5) 74 (61) 42 (34) | 5 (4) 79 (66) 35 (30) |
| Preputial aspect, n (%) Complete Uncomplete | 0 (0) 122 (100) | 1 (1) 118 (99) |
| Previous treatment with androgen, n (%) | 13 (11) | 14 (12) |
| Previous treatment with HCG, n( %) | 9 (7) | 7 (6) |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
